Malaria Author: Rick M. Fairhurst, MD, PhD; Thomas E. Wellems, MD, PhD
Module updated - 2009-11-19
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up
Tables
Figures
References
Glossary
What's New
Patient Information
Additional Resources
Tools
Consultation for Management

Consult specialists in infectious diseases and other services as appropriate. BC

  • Consider consultation with:
    • Infectious diseases specialists early to help manage patients who present with a travel history and clinical presentation suggesting either severe malaria or bacterial sepsis
    • Pharmacy services to help with rapid acquisition and preparation of quinidine and for advice on its safe administration
    • Cardiology specialists to assist in the administration of quinidine to patients with known cardiac conduction abnormalities or in whom quinidine administration prolongs the corrected QT interval
    • Neurology specialists for the management of recurrent or therapy-refractory seizures or to confirm clinically suspected nonconvulsive status epilepticus by electroencephalography
    • Renal specialists for hemodialysis management of acid-base disturbances or volume overload
    • Hematology services to prepare for the use of exchange transfusion in patients who meet WHO criteria
  • If specialist consultation is not readily available, direct questions about the management of malaria to the CDC Malaria Hotline (770-488-7788) at any hour.
Background

FAQs
Harry Tagbor, MBChB, DrPH, editorial consultant, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Rick M. Fairhurst, MD, PhD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Thomas E. Wellems, MD, PhD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott.

The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.